Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
Ashoke R KhanwalkarAakanksha RathorAmelia K ReadHassan PaknezhadYifei MaPeter H HwangPublished in: International forum of allergy & rhinology (2022)
The addition of a single treatment of submucosal bevacizumab may be associated with additional clinically meaningful benefit for up to 4 months when compared with electrocautery alone.